SBJ Pharmaceuticals Private Limited

SBJ Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U33100DL2020PTC369913 Incorporated 14 September 2020 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹28.83 Lakh
Latest filing
Net profit · FY 2024
₹7,806
Net margin 0.3%
EBITDA · FY 2024
₹10,548
EBITDA margin 0.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About SBJ Pharmaceuticals Private Limited

Data last updated:

SBJ Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2020PTC369913. Its GSTIN is 07ABECS4501L1ZB (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikas Bakshi and Jitender Kumar Madan.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fno. 301 T/F Blk B2A Sec 18 B Pkt 2 Dwarka New Delhi, Delhi, India – 110075.

As per the financials filed for FY 2024, the company reported a revenue of ₹28.83 Lakh. For the same year it recorded a net profit of ₹7,806 (net margin 0.3%) and EBITDA of ₹10,548 (EBITDA margin 0.4%).

Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

Company details

CIN U33100DL2020PTC369913
Registration Number 369913
Incorporation Date 14 September 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025

Contact details

SBJ Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Fno. 301 T/F Blk B2A Sec 18 B Pkt 2 Dwarka New Delhi, Delhi, India – 110075
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of SBJ Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
SBJ Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of SBJ Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of SBJ Pharmaceuticals Private Limited, buy the company report.

Financials of SBJ Pharmaceuticals Private Limited

FY 2025 filings available

SBJ Pharmaceuticals Private Limited reported revenue of ₹28.83 Lakh for FY 2024.

Revenue · FY 2024
₹28.83 Lakh
Net profit · FY 2024
₹7,806 margin 0.3%
EBITDA · FY 2024
₹10,548 margin 0.4%

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10,548
Profit Before Tax
Tax Expense
Net Profit (PAT)₹7,806
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.4%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of SBJ Pharmaceuticals Private Limited, buy the company report.

Board of directors of SBJ Pharmaceuticals Private Limited

SBJ Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vikas BakshiDirector14 Sep 20206 Years 1 MonthsCurrent
Jitender Kumar MadanDirector24 Sep 20206 Years 1 MonthsCurrent

Peer comparison

SBJ Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Xemda Pharmaceuticals Private Limited₹28.89 Lakh (FY 2025)-10.0%Uttam Nagar, New Delhi, Delhi, India
Melden Pharmaceuticals Private Limited₹28.86 Lakh (FY 2017)Bangalore, Karnataka, India
SBJ Pharmaceuticals Private Limitedthis company₹28.83 Lakh (FY 2024)₹7,8060.3%Delhi, India
Novotel Pharmaceuticals Private Limited₹28.82 Lakh (FY 2025)216.0%Patna, Bihar, India

To see the full peer comparison of SBJ Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for SBJ Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

SBJ Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.

Active EPFO establishments
1

GST

SBJ Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07ABECS4501L1ZBDelhiActive29 Dec 2020

To see the full GST registrations and return filing status of SBJ Pharmaceuticals Private Limited, buy the company report.

Recent activity

SBJ Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Ravi Bhatia ceased to be Director on 06 Mar 2024.

AGM
Sbj Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Sbj Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Ravi Bhatia ceased to be Director.
Appointed
Jitender Kumar Madan was appointed as Director.
Appointed
Vikas Bakshi was appointed as Director.
Incorporation
14 Sep 2020
Sbj Pharmaceuticals Private Limited was registered on 14 Sep 2020 with Roc Delhi Ii & aged 6 years 1 month as per MCA records.

Frequently asked questions

SBJ Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 September 2020 (6+ years old) and is registered under CIN U33100DL2020PTC369913.

SBJ Pharmaceuticals has 2 current directors:

The latest financial statements of SBJ Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of SBJ Pharmaceuticals is 07ABECS4501L1ZB, registered in Delhi.

The CIN (Corporate Identification Number) of SBJ Pharmaceuticals is U33100DL2020PTC369913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

SBJ Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

SBJ Pharmaceuticals was incorporated on 14 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of SBJ Pharmaceuticals by revenue are Xemda Pharmaceuticals Private Limited, Melden Pharmaceuticals Private Limited, Novotel Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).

Ravi Bhatia ceased to be Director on 06 Mar 2024. Jitender Kumar Madan was appointed as Director on 24 Sep 2020. Vikas Bakshi was appointed as Director on 14 Sep 2020.

The registered office of SBJ Pharmaceuticals is at Fno. 301 TF Blk B2A Sec 18 B Pkt 2 Dwarka New Delhi, Delhi, India – 110075.

SBJ Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.